research reports and media, page-4298

So we have gone from the last forecast by Rennie
that we would have FDA approval by late 2025, to
a forecast that we now will have approval late 2026-
early 2027. That’s following on from a statement
in 2020 that PAR would have first revenue early
2021. Six years late. No worries mate.
One of his major backers (51 Capital) was even
forecasting in 2019 that first revenue would
occur in early 2020. These people are really on
the ball aren’t they? Now they are advising
Rennie how to sail the boat. Some of those
PARates I would say.
It would appear this repurposed drug may be a
poison chalice. Maybe J&J etc. are having a
really good laugh about “passing” on the
blockbuster of the century.